Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation

This publication has 34 references indexed in Scilit:

• Opioid δ agonists and endogenous enkephalins induce different emotional reactivity than μ agonists after injection in the rat ventral tegmental area
  Psychopharmacology, 1991
• Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants
  European Journal of Pharmacology, 1990
• Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of ? and ? opioid receptors
  Psychopharmacology, 1989
• Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures
  Brain Research, 1989
• Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases
  European Journal of Pharmacology, 1989
• Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective ? and ? opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes
  Psychopharmacology, 1988
• Prevention of degradation of endogenous enkephalins produces inhibition of nociceptive neurones in rat spinal cord
  Brain Research, 1987
• Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats
  European Journal of Pharmacology, 1986
• Involvement of endogenous enkephalins in the mouse ‘behavioral despair’ test
  European Journal of Pharmacology, 1984
• Inhibition of enkepha,in metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor
  European Journal of Pharmacology, 1983